Literature DB >> 6363537

Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.

M Iwata, T F Huff, K Ishizaka.   

Abstract

Glycosylation-enhancing factor (GEF) and IgE-potentiating factor were detected in culture supernatants of rat mesenteric lymph nodes (MLN) cells obtained 14 days after infection with Nippostrongylus brasiliensis (Nb), but not in supernatants of MLN cells of 8-day Nb-infected rats. Both factors were also released from T cells upon antigenic stimulation of KLH + alum-primed spleen cells. The GEF from the Nb-infected rats and KLH + alum-primed spleen cells had affinity for p-aminobenzamidine agarose and were inactivated by phenylmethylsulfonylfluoride, an inhibitor of serine proteases. These results indicate that the GEF obtained in the two systems is a serine protease and is identical to that obtained by stimulation of normal T cells with lymphocytosis-promoting factor (LPF) from Bordetella pertussis. The concomitant formation of IgE-potentiating factor and GEF by Nb infection, by antigenic simulation of KLH + alum-primed spleen cells, and by treatment of rats with Bordetella pertussis vaccine suggests that the serine protease is involved in a common pathway leading to the selective formation of IgE-potentiating factor. In contrast, glycosylation-inhibiting factor (GIF) is always found during the selective formation of IgE-suppressive factor. IgE-suppressive factor and GIF were formed by MLN cells of 8-day Nb-infected rats and KLH-CFA-primed spleen cells. GIF was detected in culture supernatants of T cell hybridomas 23A4 and 23B6, which form unglycosylated IgE-binding factors upon incubation with IgE. GIF obtained from all of these sources bound to monoclonal anti-lipomodulin. These findings indicate that GIF or lipomodulin is involved in all systems, which leads to the selective formation of IgE-suppressive factor. However, the formation of GIF was not restricted to those conditions in which IgE-suppressive factor was selectively formed. The culture supernatants of MLN cells of 14-day Nb-infected rats and antigen-stimulated KLH + alum-primed spleen cells contained a small amount of GIF, which could be detected after inactivation of GEF. It appears that T cells from these sources formed GEF and GIF, but that GEF overcame the effect of GIF on glycosylation of IgE-binding factors. The results indicate that the nature and biologic activities of IgE-binding factors are decided by the balance between GEF and GIF formed by T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363537

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Biochemical identification of glycosylation inhibiting factor.

Authors:  K Katamura; M Iwata; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Potentiating and suppressive IgE-binding factors are expressed by a single cloned gene.

Authors:  C L Martens; P Jardieu; M L Trounstine; S G Stuart; K Ishizaka; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Purification and partial biochemical characterization of IgE-binding factors secreted by a human B lymphoblastoid cell line.

Authors:  M Sarfati; T Nakajima; H Frost; E Kilccherr; G Delespesse
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

4.  Biochemical characterization of murine glycosylation-inhibiting factor.

Authors:  Y Tagaya; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Association of I-J determinants with lipomodulin/macrocortin.

Authors:  P Jardieu; M Akasaki; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors.

Authors:  M Iwata; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

Review 8.  MIF-Dependent Control of Tumor Immunity.

Authors:  Jordan T Noe; Robert A Mitchell
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.